FDA warns about use of certain glucose monitoring strips

Share this content:
The Food and Drug Administration Friday issued a public health notification regarding certain glucose monitoring strips. Providers should not use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinine) test strips on patients receiving therapeutic products containing non-glucose sugars, the agency warned.